MD and associate professor Sami Ventelä receives a grant of 300,000€ from the Jane and Aatos Erkko foundation
The goal of Sami Ventelä’s research is to develop novel biomarker-based methods for early detection of cancer aggressiveness and for cancer treatment stratification.
– This is a great recognition for our research consortium. With the help of this proof-of-concept funding, we are able to test and develop the functionality of our methods in identifying the cancer aggressiveness and drug sensitivity in prospective setting. Moreover, we are now able to study the functionality of our findings in cancer treatment stratification. With this funding, we are also able to hire a dissertation worker or a postdoctoral researcher for the project in 2023. Our goal is nothing more and nothing less than to find new methods for us in the hospital, to improve the treatment guidance and life expectancy of head and neck cancer patients, says Sami.
Recent Posts
-
Christel Sourander Successfully Defends Her Thesis
Christel Sourander successfully defended her thesis: “Identifying the effect of JNK on neural activity and Read moreSeptember 9, 2025
-
Researchers at Åbo Akademi University Discover a New Molecular Switch Regulating Breast Cancer Progression
A research group led by our our affiliated group leader Professor Lea Sistonen at Åbo Read moreSeptember 4, 2025
-
Autumn 2025 Frontiers of Science seminars start soon
Frontiers of Science is a long-running seminar series, celebrating over 25 years of bringing internationally Read moreSeptember 3, 2025
-
The Elias Tillandz Prize to Turku Bioscience Researchers
The Elias Tillandz Prize for the Best Scientific Publication of 2024 was presented for two Read moreSeptember 2, 2025
-
Registration to FFGC Sequencing day is open!
Registration to FFGC Sequencing day is open! The event is organized by Finnish Functional Genomics Read moreAugust 27, 2025
-
Dr. Inna Starskaia received a three-year training award from Breakthrough T1D
Dr. Inna Starskaia has been awarded a prestigious three-year training award from Breakthrough T1D, the Read moreAugust 22, 2025